Targeting Angiogenesis in Bladder Cancer [News in Brief]

Ramucirumab combined with docetaxel improves progression-free survival in patients with advanced or metastatic disease.

from Cancer via ola Kala on Inoreader http://ift.tt/2yZip6K
via IFTTT